Hexagon Nutrition IPO
Open Date
5 Jun 2026
Close Date
9 Jun 2026
Open Date
5 Jun 2026
Close Date
9 Jun 2026
Min Investment
Lot Size
Issue Size
Price Range
Subscribed

Founded In
1993
CEO
Arun Purushottam Kelkar
Financials of Hexagon Nutrition IPO
| Key Performance Indicators | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating Revenue | 278.50 | 297.73 | 324.93 |
| Other Income | 3.15 | 6.89 | 6.36 |
Total Income | 281.65 | 304.62 | 331.29 |
Total Expenses | 267.02 | 285.48 | 296.78 |
| Profit Before Tax | 9.42 | 19.50 | 33.72 |
Total Profit | 5.82 | 12.21 | 24.38 |
All figures are in crores (₹)

Utilisation of Proceeds
All figures are in crores (₹)
| Purpose | Amount |
|---|---|
| The company is conducting an Offer for Sale of up to 30,859,704 Equity Shares by the Selling Shareholders. The company will not receive any proceeds from this offer as all proceeds will go to the Selling Shareholders. | - |
| The company expects that the proposed listing of its Equity Shares will enhance its visibility and brand image as well as provide liquidity and a public market for the Equity Shares in India. | - |

- Fully integrated holistic nutrition company offering end-to-end solutions: The company operates as a holistic nutrition player offering products across the whole range from micronutrient premixes to therapeutic and clinical products, managing the complete value chain in-house from research and development to manufacturing and marketing.
- Market leader in customized micronutrient formulations: The company is one of the largest premix players in India, offering customised vitamin and mineral premixes to leading Indian and multinational FMCG companies, and one of the largest licensed suppliers of Micronutrient Powders (MNPs) under UN programmes.
- Recognized wellness and clinical nutrition brand in the market: The company has progressively moved up the value chain with development of in-house brands such as PENTASURE, OBESIGO, and PEDIAGOLD, with global footprint across 75+ countries and regulatory approvals in over 14 countries.
- Long Standing Relationships with customers: The company served 423 customers during nine months ended December 31, 2025, with 286 repeat customers, demonstrating strong customer retention across B2C, B2B2C and ESG segments with revenue predictability and operational stability.
- Established R&D capabilities with focus on innovation: The company operates two dedicated in-house R&D facilities with 12 professionally qualified members, developing 11 new products during the period, with consistent R&D investment of 0.75% of revenue from operations.
- Manufacturing capabilities with quality and food safety procedures: The company operates three manufacturing facilities in India and one international facility in Uzbekistan, with certifications including FSSC 22000, GMP certification, and ISO 9001:2015, ensuring quality standards across the production chain.
- Well established pan India omnichannel distribution: The company has pan-India distribution through 358 non-exclusive distributors, sales force of 167 members reaching over 20,000 healthcare professionals, and international presence across 20 regional distributors covering 75+ countries.
- Professional entrepreneur promoters with experienced management team: The company is founded by promoters with over three decades of experience, supported by qualified management team with significant experience in nutrition industry and in-depth understanding of target markets and consumer preferences.
- Track record of growth in financial performance: The company demonstrated consistent growth with revenue from operations growing from ₹2,785.01 million in Fiscal 2023 to ₹3,249.29 million in Fiscal 2025, and profit after tax growing from ₹58.24 million to ₹243.77 million.

